DXCM vs WST · P/E 63, rev $2.50B vs P/E 35, rev $1.72B
DexCom Inc (DXCM) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the DXCM and WST stock pages for the full models.
Not investment advice.